WSI24-68-Case-4

From MGH Learn Pathology
Revision as of 15:26, April 3, 2024 by Si787 (talk | contribs) (Creating page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
WSI24-68-Case-4
41 y.o. female with breast cancer on pembrolizumab.
Immune checkpoint inhibitor therapy effect (increased intraepithelial lymphocytes)
May 6, 2024 3:30:00 PM





Retrieved from "https://learn.mghpathology.org/index.php?title=WSI24-68-Case-4&oldid=125228"
  • Powered by MediaWiki
  • Search Powered by Cargo
  • Massachusetts General Hospital